Lantheus Holdings, Inc. (LNTH) Financials
LNTH Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-03-31 | 1.8 billion | 885.8 million |
2023-12-31 | 1.7 billion | 835.3 million |
2023-09-30 | 1.5 billion | 822.9 million |
2023-06-30 | 1.3 billion | 785.1 million |
LNTH Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-03-31 | 119.0 million | 15.4 million |
2023-12-31 | 100.2 million | 14.2 million |
2023-09-30 | 102.1 million | 14.0 million |
2023-06-30 | -43.0 million | 12.7 million |
LNTH Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2024-03-31 | 131.1 million |
2023-12-31 | 103.4 million |
2023-09-30 | 132.0 million |
2023-06-30 | 94.1 million |
LNTH Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-03-31 | 718.3 million | - | 54.1 million |
2023-12-31 | 713.7 million | - | 54.5 million |
2023-09-30 | 614.1 million | - | 54.4 million |
2023-06-30 | 414.1 million | 559.2 million | 31.3 million |
LNTH Shares Outstanding
LNTH Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-03-31 | 8.3 million | 48.0 million | 47.9 million | 45.5 million |
2023-12-31 | 12.1 million | 16.8 million | 40.3 million | 35.3 million |
2023-09-30 | 14.6 million | 14.5 million | 35.7 million | 37.4 million |
2023-06-30 | 10.7 million | 15.9 million | 26.2 million | 36.5 million |
LNTH Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2024-03-31 | 370.0 million | 118.2 million |
2023-12-31 | 354.0 million | 124.1 million |
2023-09-30 | 319.9 million | 120.0 million |
2023-06-30 | 321.7 million | 119.1 million |
LNTH
Price: $78.22
52 week price:
Earnings Per Share: 4.65 USD
P/E Ratio: 36.66
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 24390
Ebitda: 17.5 millionMarket Capitalization: 5.3 billion